| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 05/24/2006 | EP1658881A1 Compositions for metabolic protection and repair of lips |
| 05/24/2006 | EP1658858A2 Use of botulinum toxin for the treatment of unstable bladder |
| 05/24/2006 | EP1658857A1 Compositions and methods for treating lysosomal storage disease |
| 05/24/2006 | EP1658856A1 Exendins for glucagon suppression |
| 05/24/2006 | EP1658855A2 Use of substance p for mobilization or proliferation of mesenchymal stem cells and for wound healing |
| 05/24/2006 | EP1658849A2 Therapeutic combinations of antihypertensive and antiangiogenic agents |
| 05/24/2006 | EP1658369A2 Method to inhibit the propagation of an undesired cell population |
| 05/24/2006 | EP1658312A1 Modulators of the potassium channels twik-1, task-1, girk1, sk2 or pcn1, used to treat arrhythmia, coronary heart disease or hypertension |
| 05/24/2006 | EP1658311A2 Enhancing the circulating half-life of interleukin-2 proteins |
| 05/24/2006 | EP1658309A2 Peptide protein translation inhibitor and the use thereof for protein translation control |
| 05/24/2006 | EP1658307A2 Methods for the early diagnosis of ovarian cancer |
| 05/24/2006 | EP1658304A2 Influenza therapeutic |
| 05/24/2006 | EP1658097A1 Nucleotide and cellular vaccine composition |
| 05/24/2006 | EP1658096A1 Method of inducing immune tolerance |
| 05/24/2006 | EP1658094A1 C1-inh as a drug for treating viruses pathogenic to humans |
| 05/24/2006 | EP1658093A2 Use of a mixture containing neuropeptides and steroids for treating disturbances of psychosocial experiences and behaviour |
| 05/24/2006 | EP1658092A1 A method for treating cancer patients undergoing chemotherapy |
| 05/24/2006 | EP1658091A1 Pharmaceutical compositions comprising an epitope of platelet gpiiia protein |
| 05/24/2006 | EP1658090A2 Agent and method for the treatment and prevention of tse and method for the production of said agent |
| 05/24/2006 | EP1658089A2 Compositions for treating pathologies that necessitate suppression of gastric acid secretion |
| 05/24/2006 | EP1658088A1 Prebiotically active plant extracts |
| 05/24/2006 | EP1658078A2 Methods for intradermal delivery of therapeutics agents |
| 05/24/2006 | EP1658050A1 Self-nanoemulsifying oily formulation for the administration of poorly water-soluble drugs |
| 05/24/2006 | EP1658046A1 Mucoadhesive composition comprising polyacrylate and chemoattractant |
| 05/24/2006 | EP1658036A2 Estrogen receptor modulators and uses thereof |
| 05/24/2006 | EP1471944B1 Pharmaceutical composition which improves in vivo gene transfer |
| 05/24/2006 | EP1466614A4 Polypeptide, the conjugate thereof containing doxorubicine and a pharmaceutical composition based thereon |
| 05/24/2006 | EP1427428B1 Apoptosis-mimicking natural vesicles and use thereof in medical treatment |
| 05/24/2006 | EP1414420B1 Method for the continuous production and coating of self-adhesive compounds on the basis of sbc that includes at least one pharmaceutically active substance |
| 05/24/2006 | EP1373305B1 Process for producing trunkamide a compounds |
| 05/24/2006 | EP1337550B1 Hepatitis c tripeptide inhibitors |
| 05/24/2006 | EP1333841B1 M. tuberculosis chaperonin 10 and uses thereof |
| 05/24/2006 | EP1257568B1 Novel echinocandin derivatives, preparation method and use thereof as fungicides |
| 05/24/2006 | EP1252183B1 Method for reducing the immunogenicity of staphylokinase by elimination of t-cell epitopes |
| 05/24/2006 | EP1212410B1 Dna encoding the human serine protease eos |
| 05/24/2006 | EP1141305B1 Chimeric gene encoding the antigenic determinants of four proteins of l. infantum |
| 05/24/2006 | EP1121382B1 Interferon-beta fusion proteins and uses |
| 05/24/2006 | EP1115397B1 Compositions for mitigating the adverse effects of interleukin-2 |
| 05/24/2006 | EP1071443B1 Isolated peptides corresponding to amino acid sequences of ny-eso-1, wherein bind to mhc class i and mhc class ii molecules, and uses thereof |
| 05/24/2006 | EP1061887B1 Novel use of phospholipids of vegetable and animal origin in nutritional therapy |
| 05/24/2006 | EP1015585B1 Tie ligand homologues |
| 05/24/2006 | EP1009419B1 Method for identifying modified recombinant Graminae pollen allergens |
| 05/24/2006 | EP1002075B1 Adipocyte-specific protein homologs |
| 05/24/2006 | EP1001974B1 4-amino-phenylalanine type compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 05/24/2006 | EP0973563B1 System for dialysis and shock treatment |
| 05/24/2006 | EP0907733B1 Novel inhibitors of vascular endothelial growth factor activity, their uses and processes for their production |
| 05/24/2006 | EP0892809B1 Fhit proteins and nucleic acids and methods based thereon |
| 05/24/2006 | EP0872488B1 MONOCLONAL ANTIBODY REACTING SPECIFICALLY WITH Fas LIGAND AND PROCESS FOR PRODUCING THE SAME |
| 05/24/2006 | EP0858337B1 A pharmaceutical composition for the treatment of autoimmune diseases |
| 05/24/2006 | EP0719295B1 Polymeric matrices and their uses in pharmaceutical compositions |
| 05/24/2006 | DE19543271B4 Orales pharmazeutisches Präparat An oral pharmaceutical composition |
| 05/24/2006 | DE102004055891A1 Kit for treating cancer, autoimmune diseases, immune deficiency diseases, and as accompanying therapy for bacterial and viral infections, comprises a mixture of snake toxins from at least three different types of snakes |
| 05/24/2006 | CN1777680A Methods of inducing the expression of bone morphogenetic proteins (BMPs) and transforming growth factor-beta-proteins (TGF-ª‰s) in cells |
| 05/24/2006 | CN1777678A Method of treating ischemic disease |
| 05/24/2006 | CN1777445A Agent for repairing corneal perception |
| 05/24/2006 | CN1777443A Methods of diagnosing and treating pre-eclampsia or eclampsia |
| 05/24/2006 | CN1777440A Method for preparation of site-specific protein conjugates |
| 05/24/2006 | CN1777439A Somatostatin vectors |
| 05/24/2006 | CN1777438A Treatment or prevention of respiratory viral infections with alpha thymosin peptides. |
| 05/24/2006 | CN1777437A Biologically active native biomatrix composition |
| 05/24/2006 | CN1777436A Anti-angiogenic and anti-tumoral properties of beta and gamma secretase inhibitors |
| 05/24/2006 | CN1777435A Method of purifying polypeptides by simulated moving bed chromatography |
| 05/24/2006 | CN1777424A Antineoplastic combination drug |
| 05/24/2006 | CN1777414A Glycinamide derivative for inhibiting HIV replication |
| 05/24/2006 | CN1777363A Ss-l-2'-deoxynucleosides for the treatment of resistant HBV strains and combination therapies |
| 05/24/2006 | CN1775946A Enhanced virus-mediated DNA transfer |
| 05/24/2006 | CN1775804A UreG protein, and its preparing method and sue |
| 05/24/2006 | CN1775801A Low molecular weight peptide derivatives as inhibitors of the laminin/nidogen interaction |
| 05/24/2006 | CN1775286A Vaccine for preventing and/or treating tumour of digestive system |
| 05/24/2006 | CN1775285A Use of glucoprotein for pharmaceuticals |
| 05/24/2006 | CN1775284A Blood-viscosity reducing agent |
| 05/24/2006 | CN1775283A Reduced glutathione eye medicinal preparation |
| 05/24/2006 | CN1257284C Method of blocking expression of hepatitis B virus |
| 05/24/2006 | CN1257271C Serine proteinase and coded sequence thereof |
| 05/24/2006 | CN1257187C Calreticulin-tumor necrosis factor correlated apoptosis inducing ligand fusion protein and its prearation and use |
| 05/24/2006 | CN1257186C Interferon gamma polypeptide variants |
| 05/24/2006 | CN1256984C Isulin solid granular, its preparation method and its use in preparing medicine for treating diabetes |
| 05/24/2006 | CN1256983C Use of mannan peptide in preparation of immunologic enhancement medication which is topically and orally applicated |
| 05/24/2006 | CN1256982C Combinations of dalfopristine/quinupristine with cefpirome |
| 05/24/2006 | CN1256981C Medicine for treating piglet white scour and its preparation method |
| 05/24/2006 | CN1256936C Skin care compositions containing osamine |
| 05/23/2006 | US7049431 Antisense antibacterial cell division composition and method |
| 05/23/2006 | US7049430 Method of treating HIV infection and related secondary infections thereof |
| 05/23/2006 | US7049423 Nucleic acids coding fuion protein; gene expression |
| 05/23/2006 | US7049422 Tumor necrosis related receptor, TR7 |
| 05/23/2006 | US7049420 Using gene product; polynucleotides; antitumor, anticancer agent |
| 05/23/2006 | US7049418 Nucleotide sequences coding polypeptides for use in the treatment and prevention of infections |
| 05/23/2006 | US7049416 Phosophoinositoglycan binding proteins |
| 05/23/2006 | US7049415 Pegylated T20 polypeptide |
| 05/23/2006 | US7049414 Complex of lecithin and sugar; immobilization; washing; liquid removal; recovering |
| 05/23/2006 | US7049413 MAGE-A3 peptides presented by HLA class II molecules |
| 05/23/2006 | US7049412 Genetic engineered nucleic acids codes these enzymes; therapy for bone disorders; monoclonal antibodies |
| 05/23/2006 | US7049411 Human anti-factor IX/IXa antibodies |
| 05/23/2006 | US7049407 Antibody for use in the detection of preferential enzyme expression; for use as tool in treatment and detection of enzyme defects; for treatment autoimmune disease, inflammation, sepsis, diabetes, kidney defects and cancer |
| 05/23/2006 | US7049406 Amplified genetic expression of genetically engineered hemoglobin; obtain cell, transform with vector coding genetically engineered hemoglobin, express vector, recover hemoglobin |
| 05/23/2006 | US7049405 α-helical protein based materials and methods for making same |
| 05/23/2006 | US7049403 Insulin/IGF/relaxin family polypeptides and DNAS thereof |
| 05/23/2006 | US7049402 Tumor necrosis factor receptor-5 |
| 05/23/2006 | US7049399 Making glatiramer acetate; polymerization of the N-carboxyanhydrides of L-alanine, tyrosine, gamma -benzyl glutamate and N epsilon-benzyloxycarbonyl lysine to make a protected copolymer, and deprotecting, separation and purification, in various solvents |
| 05/23/2006 | US7049398 Melanocortin metallopeptide constructs, combinatorial libraries and applications |